Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Resverlogix Corp T.RVX

Alternate Symbol(s):  RVXCF

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.


TSX:RVX - Post by User

Bullboard Posts
Comment by amorakon Oct 07, 2011 1:56pm
124 Views
Post# 19130527

RE: RE: RE: : @ amorak

RE: RE: RE: : @ amorak
I didn't think you could read my post and understand it!
.
The only thing I predicted was that you wouldn't answer my questions and that you wouldn't understand what I wrote!
.
You are predictable, I'll give you that.
.
I said that 50 cents would be nice but that I believe too many people have a higher entry point than that. Therefore, without determined manipulation, such a drop may stall at 80 cents or so because the buying will be too strong. The price of 80 cents is just below the optics of $1 and I don't think buyer can kepp from pulling the trigger on that.
.
And yes I am buying now (some, not much) because it may never drop much lower.
.
Now pay attention. The bet is a binary one, NexVas success or failure. The only non-binary part is the stock's behaviour before resolution and that behaviour should present opportunity for flipping, capital preservation, maybe even a risk-free home run.
.
Meanwhile, the binary bet is maybe the best one available. The risk is small because resolution can't happen for a year and the chance for success is greater than 50%, not infintesimly small as you recently offered. (Success is getting to phase three.) If it does, RVX is worth more than a billion dollars, maybe 2 to 3 billions because the potential gross sales of RVX208 over 20 years is more than 200 billion dollars. (10 billion/yr x 20 yrs). It's more if Alzheimer's and inflammation come into play. You can do the discounted and adjusted NPV on that. You probably have already, as I have.
.
So hell yeah, I'm hoping for low values here but I'll play what the market gives me, safe in the knowledge that the market will ultimately have no say in the valuation of RVX.
.
I should explain what a short is so that you won't ask such a stupid question again. A short is a sell, not a buy. I have been buying at this level, a few. At 80 cents I will most certainly be buying. It's great money - when it comes back to $1.20 I will have a 50% profit on those purchases. But most investors (except you, it seems) know this so that's why 50 cents is pretty hard to imagine. So is it a short opportunity? Certainly not if you're treating RVX as a speculative stock because the reward of the short isn't worth the risk. At least, it's certainly not the definition of "speculative". 
.
And I would agree with you that buying now and selling at 80 cents does not constitute wise investing. (snore...)
.
I would be buying more now but I think biOasis (V.BTI) will move more quickly and that the BTO/RVX timing favours BTI first and profit from that back into RVX. I think we have a monster 18 months ahead of us. Unless you own krill oil or something without much risk like that. But I like risk when it comes to spec stocks. Low risk - low reward! High risk - high reward! NTB has too little risk to be really rewarding. It belongs in a different part of the portfolio, and in a different discussion.
.
But you still have a backlog of questions to answer, viking. Should I restate them? There are a half dozen or so.
.
Bullboard Posts